Warfarin Self-Monitoring Superior to Clinic Management August 18, 1999 - Two researchers presented data today showing that patients who monitor their own oral Coumadin dose may do better than those who are managed in a clinic. The research was given at the 27th International Congress on Thrombosis and Haemostasis. Herbert Watkze compared 49 Austrian patients who were taught to self-test INR levels and manage their own dosage with 53 patients seen at the university's outpatient anti-coagulation clinic. INR levels were tested weekly in each group for 3 months. Self-monitoring patients were told to aim for a specific target value and were also asked to keep their INR withing a specific range at all times. 84% of self-management patients kept their INR within range, compared to 78% of those seen at the clinic. Self- monitoring patients came very close to hitting their intended average INR over one year. For self-monitoring patients with artificial heart valves, the intended average was 3.2, and after a year, patients hit an average of 3.15. For clinic-managed patients with artificial valves, the target was 3.5, and a year later, the actual average was 3.19. Dr. Watzke concluded that a self-management protocol is slightly better than conventional management. Dr. M. Cromheecke of the University of Amsterdam, who also studied Coumadin self-management, reached a more cautious conclusion. She enrolled 50 patients, most of whom were receiving Coumadin because of prosthetic heart valves. They were assigned to either self-management or clinic management for the first 3 months, and then crossed over to the opposite method. Patients spent 58% of the time within their target INR range while self-managing and 51% of their time within range as clinic patients. When self-managing, patients had a lower incidence of serious under- or over-anticoagulation; 3.5% compared with 5.3% for clinic patients. Dr. Cromheecke said that self-management was at least as effective as clinic management, but she added that longer term studies are needed.